Tumorigenicity and genetic profiling of circulating tumor cells in small-cell lung cancer
暂无分享,去创建一个
Mahmood Ayub | Dominic G Rothwell | Caroline Dive | Ged Brady | Crispin J. Miller | Catriona Tate | Yaoyong Li | S. Pepper | C. Dive | F. Blackhall | D. Nonaka | L. Carter | R. Metcalf | M. Krebs | K. Morris | D. Rothwell | D. Burt | F. Trapani | C. Morrow | K. Simpson | C. Hodgkinson | L. Priest | A. Greystoke | G. Brady | Fiona Blackhall | Yaoyong Li | Crispin J Miller | Cassandra L Hodgkinson | Christopher J Morrow | Robert L Metcalf | Francesca Trapani | Radoslaw Polanski | Deborah J Burt | Kathryn L Simpson | Karen Morris | Stuart D Pepper | Daisuke Nonaka | Alastair Greystoke | Paul Kelly | Becky Bola | Matthew G Krebs | Jenny Antonello | Suzanne Faulkner | Lynsey Priest | Louise Carter | M. Ayub | J. Antonello | P. Kelly | S. Faulkner | B. Bola | C. Tate | R. Polanski | Becky M. Bola
[1] R. Livingston,et al. Improved chemotherapy for small-cell undifferentiated lung cancer. , 1976, JAMA.
[2] Emmanuel Barillot,et al. Control-free calling of copy number alterations in deep-sequencing data using GC-content normalization , 2010, Bioinform..
[3] S. Schwartz,et al. Prostate cancer and other xenografts from cells in peripheral blood of patients. , 2000, Cancer research.
[4] C. Belani,et al. Small-cell lung cancer: an update on targeted therapies. , 2013, Advances in experimental medicine and biology.
[5] C. Swanton. Intratumor heterogeneity: evolution through space and time. , 2012, Cancer research.
[6] R. Davenport. Diagnostic value of crush artifact in cytologic specimens. Occurrence in small cell carcinoma of the lung. , 1990, Acta cytologica.
[7] M. Poupon,et al. Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates. , 1993, Journal of the National Cancer Institute.
[8] J. Minna,et al. Establishment of continuous, clonable cultures of small-cell carcinoma of lung which have amine precursor uptake and decarboxylation cell properties. , 1980, Cancer research.
[9] B. Horsthemke,et al. Identification of RB1 germline mutations in Argentinian families with sporadic bilateral retinoblastoma. , 1995, Journal of medical genetics.
[10] Giovanni Parmigiani,et al. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. , 2009, Cancer research.
[11] N. Stoecklein,et al. Genetic heterogeneity of single disseminated tumour cells in minimal residual cancer , 2002, The Lancet.
[12] Wainer Zoli,et al. Detection and recovery of circulating colon cancer cells using a dielectrophoresis-based device: KRAS mutation status in pure CTCs. , 2013, Cancer letters.
[13] H. Hakonarson,et al. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data , 2010, Nucleic acids research.
[14] Daniel F. Hayes,et al. Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer , 2013 .
[15] M. DePristo,et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.
[16] Y. Shimosato,et al. A new floating cell line derived from human pulmonary carcinoma of oat cell type. , 1971, Gan.
[17] G. T. Budd,et al. Circulating Tumor Cells at Each Follow-up Time Point during Therapy of Metastatic Breast Cancer Patients Predict Progression-Free and Overall Survival , 2006, Clinical Cancer Research.
[18] K. Cibulskis,et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer , 2012, Nature Genetics.
[19] Tim Holland-Letz,et al. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay , 2013, Nature Biotechnology.
[20] Jonathan W. Uhr,et al. Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.
[21] B. Lorenz,et al. Constitutional RB1-gene mutations in patients with isolated unilateral retinoblastoma. , 1997, American journal of human genetics.
[22] Z. Szallasi,et al. Parallel evolution of tumour subclones mimics diversity between tumours , 2013, The Journal of pathology.
[23] F. Rojo,et al. Genetic changes in small cell lung carcinoma , 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[24] M. Ychou,et al. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts , 2010, Nucleic acids research.
[25] A. Fersht,et al. The tumor suppressor p53: from structures to drug discovery. , 2010, Cold Spring Harbor perspectives in biology.
[26] E. Birney,et al. A small cell lung cancer genome reports complex tobacco exposure signatures , 2009, Nature.
[27] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[28] Peter Ulz,et al. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. , 2013, Cancer research.
[29] D. Osoba,et al. VP‐16 alone and in combination with cisplatin in previously treated patients with small cell lung cancer , 1984, Cancer.
[30] K. Pienta,et al. Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer , 2008, Clinical Cancer Research.
[31] R. Wittes,et al. cis-Dichlorodiammineplatinum(II) and VP-16-213: an active induction regimen for small cell carcinoma of the lung. , 1979, Cancer treatment reports.
[32] D. Osoba,et al. VP-16 and cisplatin as first-line therapy for small-cell lung cancer. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] M. Hidalgo,et al. Prioritizing phase I treatment options through preclinical testing on personalized tumorgraft. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] Rudolf M. Huber,et al. Combined transcriptome and genome analysis of single micrometastatic cells , 2002, Nature Biotechnology.
[35] J. Minna,et al. Molecular genetics of small cell lung carcinoma. , 2001, Seminars in oncology.
[36] Caroline Dive,et al. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] Caroline Dive,et al. Molecular analysis of circulating tumour cells—biology and biomarkers , 2014, Nature Reviews Clinical Oncology.
[38] Caroline Dive,et al. Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] A. Berns,et al. Mouse models for lung cancer , 2013, Molecular oncology.
[40] Michal J. Okoniewski,et al. X:Map: annotation and visualization of genome structure for Affymetrix exon array analysis , 2007, Nucleic Acids Res..
[41] A. Sieuwerts,et al. Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting , 2013, British Journal of Cancer.
[42] W. William,et al. Novel strategies for the treatment of small-cell lung carcinoma , 2011, Nature Reviews Clinical Oncology.
[43] Bert Vogelstein,et al. DETECTION OF CIRCULATING TUMOR DNA IN EARLY AND LATE STAGE HUMAN MALIGNANCIES , 2014 .
[44] X. Xie,et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients , 2013, Proceedings of the National Academy of Sciences.
[45] M. Hollingshead,et al. Real-time PCR-based assay to quantify the relative amount of human and mouse tissue present in tumor xenografts , 2011, BMC biotechnology.
[46] J. Izbicki,et al. Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer. , 2013, Clinical chemistry.
[47] A. Berns,et al. Induction of small cell lung cancer by somatic inactivation of both Trp53 and Rb1 in a conditional mouse model. , 2003, Cancer cell.
[48] Steven J. M. Jones,et al. Circos: an information aesthetic for comparative genomics. , 2009, Genome research.
[49] Caroline Dive,et al. Tumorigenesis and Neoplastic Progression Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy , 2010 .
[50] M. Choti,et al. Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies , 2014, Science Translational Medicine.
[51] M. Cristofanilli. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2006, Seminars in oncology.
[52] Robert Gentleman,et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer , 2012, Nature Genetics.
[53] C. Klein. Selection and adaptation during metastatic cancer progression , 2013, Nature.
[54] M. Ranson,et al. Isolation and Extraction of Circulating Tumor DNA from Patients with Small Cell Lung Cancer , 2008, Annals of the New York Academy of Sciences.
[55] A. Okamoto,et al. Variable mutations of the RB gene in small-cell lung carcinoma. , 1990, Oncogene.